Back
ESC Premium Access

Poster session 4 - Fighting againts diabetes epidemic

Event: ESC CONGRESS 2016
Topic: Miscellaneous
Session type: Poster Session
Date: 29 August 2016

Congress Session

0
17 presentations in this session

Angiopoietin-like 2 is associated with increased risk of death in diabetic patients

Speaker: Doctor B. Gellen (Poitiers, FR)
Access
Abstract
0
Thumbnail

Glycosylated haemoglobin predicts mortality in patients with heart failure and unknown diabetes - insights from the Swedish heart failure registry (SwedeHF)

Speaker: Doctor I. Johansson (Stockholm, SE)
Access
Abstract
0
Thumbnail

Epicardial adipose tissue and cardiovascular disease in type 2 diabetes

Speaker: Doctor R. Christensen (Copenhagen, DK)
Access
Abstract
Slides
0
Thumbnail

Arterial stiffness as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes

Speaker: Mr S. Sharif (Utrecht, NL)
Access
Abstract
Slides
0
Thumbnail

Plasma dehydroepiandrosterone levels are inversely associated with the risk of type 2 diabetes: the Rotterdam Study

Speaker: Miss A. Brahimaj (Rotterdam, NL)
Access
Abstract
Slides
0
Thumbnail

Are the LDL-cholesterol targets from the ESC/EASD guidelines achievable in diabetic patients?

Speaker: Doctor J. Dillinger (Paris, FR)
Access
Abstract
Slides
0
Thumbnail

Triglyceride/high-density lipoprotein cholesterol ratio associates with plaque instability in diabetic patients receiving a statin: frequency domain optical coherence tomography analysis

Speaker: Doctor Y. Kataoka (Suita, JP)
Access
Abstract
0
Thumbnail

Triglyceride to HDL-C ratio is associated with high risk coronary plaques characterized with coronary CT angiography in patients with suspected coronary artery disease

Speaker: Doctor Y. Koide (Okayama, JP)
Access
Abstract
Slides
0
Thumbnail

Ethnic and regional variation in diabetes among Asian patients with heart failure

Speaker: Professor C. Lam (Singapore, SG)
Access
Abstract
0
Thumbnail

Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms.

Speaker: Professor M. Banach (Lodz, PL)
Access
Abstract
Slides
0
Thumbnail

17 speakers from this session

Doctor Barnabas Gellen

Polyclinic of Poitiers Elsan, Poitiers (France)
0 follower

Doctor Isabelle Johansson

Karolinska Institute, Stockholm (Sweden)
2 presentations
0 follower

Doctor Regitse Hoejgaard Christensen

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
0 follower

Mr Shahnam Sharif

University Medical Center Utrecht, Utrecht (Netherlands (The))
0 follower

Miss Adela Brahimaj

Erasmus Medical Center, Rotterdam (Netherlands (The))
0 follower

Doctor Jean-Guillaume Dillinger

Lariboisiere APHP Site of Saint Louis University Hospital, Paris (France)
0 follower

Doctor Yu Kataoka

National Cerebral & Cardiovascular Center, Suita (Japan)
0 follower

Doctor Yuji Koide

, Okayama (Japan)
0 follower

Professor Carolyn Sp Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)
102 presentations
16 followers

Professor Maciej Banach

Medical University of Lodz, Lodz (Poland)
4 presentations
0 follower

Professor Andre La Gerche

Baker Heart and Diabetes Institute, Melbourne (Australia)
22 presentations
2 followers

Doctor Gaia Spinetti

IRCCS - MultiMedica, Milan (Italy)
0 follower

Mr Iurii Stafeev

National Medical Research Center for Cardiology, Moscow (Russian Federation)
0 follower

Doctor Hideki Wada

Juntendo University Shizuoka Hospital, Izunokuni (Japan)
0 follower

Doctor Ignatios Ikonomidis

National & Kapodistrian University of Athens, Athens (Greece)
5 presentations
2 followers

Assistant Professor Biljana Parapid

Faculty of Medicine, University of Belgrade, Belgrade (Serbia)
0 follower

Doctor Tomohiro Shimizu

, Fukui (Japan)
0 follower

This platform is supported by

logo Novo Nordisk